Poorer and Minority Patients Less Likely to Receive Opioid Prescriptions

Published Online: Wednesday, August 7, 2013
Follow Pharmacy_Times:
Poorer patients and minorities are less likely to be prescribed opioids in emergency departments than wealthier white patients, according the results of a study published in the June 2013 issue of the Journal of General Internal Medicine.

The study examined the relationship between patients’ neighborhood, socioeconomic status, and racial identity and the frequency of opioid prescriptions for moderate to severe pain in emergency departments. Using data from the National Hospital Ambulatory Medical Care Survey, the researchers identified more than 50,000 patients who were prescribed opioids during emergency department visits between 2006 and 2009. Patients’ socioeconomic status was evaluated based on their home zip code.

Patients within the highest quartile of socioeconomic status were more likely to receive opioids than patients within the lowest quartile. Just under half of patients from zip codes with the lowest poverty rates were prescribed opioids, compared with 39% of patients from areas with the highest poverty rates. In addition, 46% of white patients were prescribed painkillers, compared with just 39% of African American patients, and 40% of Hispanic patients received opioids, compared with 45% of non-Hispanic patients. The results indicated that patients’ race played an important role in prescription patterns even after accounting for differences in socioeconomic status.

Related Articles
Dispensing higher opioid doses to chronic pain patients could trigger depression.
While extended-release opioid analgesics are an essential component of pain management, abuse and misuse of these medications can cause substantial morbidity and mortality.
The rate of deaths from opiate medications in the United States has increased 4-fold over the past decade.
With Americans’ use of opioids increasing, a panel from the National Institutes of Health set out to measure the drugs’ effectiveness in treating long-term chronic pain, and its report suggested that the risks outweigh the benefits.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$